Insmed (INSM) Goodwill & Intangibles (2010 - 2026)
Insmed's (INSM) quarterly Goodwill & Intangibles came in at $231.7 million in Q1 2026, up 70.22% year-on-year from $136.1 million in Q1 2025, and down 0.89% quarter-over-quarter from $233.8 million in Q4 2025.
Insmed (INSM) Goodwill & Intangibles (2010 - 2026) Analysis & Trends
Insmed's Goodwill & Intangibles history runs 17 years deep, the most recent figure standing at $231.7 million for Q1 2026.
- On a quarterly basis, Goodwill & Intangibles rose 70.22% year-over-year to $231.7 million in Q1 2026; TTM through Mar 2026 was $231.7 million, a 70.22% increase from a year earlier, with the FY2025 full-year figure at $233.8 million, up 20.02% from the prior year.
- Goodwill & Intangibles eased to $231.7 million in Q1 2026 per INSM's latest filing, from $233.8 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $233.8 million in Q4 2025 and bottomed at $136.1 million in Q2 2024.
- The 5-year median for Goodwill & Intangibles is $199.8 million (2023), against an average of $187.2 million.
- Across the five-year window, Goodwill & Intangibles jumped 343.74% in 2022 and plunged 34.37% in 2023, its largest moves.
- Year by year, Goodwill & Intangibles stood at $204.9 million in 2022, then fell by 2.47% to $199.8 million in 2023, then dropped by 2.52% to $194.8 million in 2024, then gained by 20.02% to $233.8 million in 2025, then retreated by 0.89% to $231.7 million in 2026.
- Per Business Quant, the three latest INSM Goodwill & Intangibles figures stand at $231.7 million (Q1 2026), $233.8 million (Q4 2025), and $220.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Insmed | 23.26 Bn | 22.03 Bn | 258.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 231.67 Mn |
| Dec 31, 2025 | 233.75 Mn |
| Sep 30, 2025 | 220.70 Mn |
| Jun 30, 2025 | 192.24 Mn |
| Mar 31, 2025 | 136.10 Mn |
| Dec 31, 2024 | 194.76 Mn |
| Sep 30, 2024 | 136.10 Mn |
| Jun 30, 2024 | 136.10 Mn |
| Mar 31, 2024 | 198.55 Mn |
| Dec 31, 2023 | 199.80 Mn |
| Sep 30, 2023 | 136.11 Mn |
| Jun 30, 2023 | 136.11 Mn |
| Mar 31, 2023 | 203.60 Mn |
| Dec 31, 2022 | 204.87 Mn |
| Sep 30, 2022 | 206.13 Mn |
| Jun 30, 2022 | 207.38 Mn |
| Mar 31, 2022 | 208.66 Mn |
| Dec 31, 2021 | 209.92 Mn |
| Sep 30, 2021 | 211.18 Mn |
| Jun 30, 2021 | 46.74 Mn |